FSD Pharma Inc. (HUGE.CN) Research

FSD Pharma Inc. functions as a biotechnology firm dedicated to the discovery and advancement of pharmaceutical products. Its main drug candidate, FSD201, is a palmitoylethanolamide currently undergoing development for addressing inflammatory conditions. Furthermore, the company is pursuing research and development into Lucid-Psych, a molecular compound targeting mental health challenges, and Lucid-MS, another molecular compound designed for neurodegenerative illnesses. FSD Pharma Inc. maintains its corporate headquarters in Toronto, Canada.

Market snapshot

Symbol
HUGE.CN
Price
$0.13
Day change
-13.79%
Market cap
$62.5K
P/E ratio
-0.15x
52-week range
0.0-144.95
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Avisa Diagnostics Inc. (AVBT.CN)
  • Gaia Grow Corp. (GAIA.CN)
  • Russell Investments Fallen Ange (HALO.NE)
  • Restart Life Sciences Corp. (HEAL.CN)
  • Imagin Medical Inc. (IME.CN)
  • Kiaro Holdings Corp. (KO.V)
  • Lowell Farms Inc. (LOWL.CN)
  • Wellbeing Digital Sciences Inc. (MEDI.NE)

Open FSD Pharma Inc. (HUGE.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.